International Study to Determine if AdreView Heart Function Scan Can be Used to Identify Patients With Mild or Moderate Heart Failure (HF) That Benefit From Implanted Medical Device
Public ClinicalTrials.gov record NCT02656329. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
AdreView™ Myocardial Imaging for Risk Evaluation - A Multicentre Trial to Guide ICD Implantation in NYHA Class II & III Heart Failure Patients With 25%≤LVEF≤35%
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is an event-driven Phase IIIb, multicentre, randomised, clinical study to demonstrate the efficacy of AdreView™ imaging for appropriately guiding the decision of implantable cardioverter defibrillator (ICD) implantation, in New York Health Association (NYHA) class II and III heart failure participants with 25%\<=left ventricular ejection fraction (LVEF)\<=35%, and in particular, for identifying participants who are at low risk for sudden cardiac death and who would not benefit, or may suffer harm, from implantation of an ICD device.
Study identification
- NCT ID
- NCT02656329
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 395 participants
Conditions and interventions
Conditions
Interventions
- Iobenguane I -123 Injection Drug
- Implantable Cardioverter Defibrillator Device
- Thyroid blocking Drug
Drug · Device
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 30, 2015 (Actual)
- Primary completion
- May 4, 2018 (Actual)
- Completion
- May 4, 2018 (Actual)
- Last update posted
- May 22, 2019
2015 – 2018
United States locations
- U.S. sites
- 29
- U.S. states
- 15
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Vascular Biology and Hypertension Program, University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Comprehensive Cardiovascular Medical Group | Bakersfield | California | 93309 | — |
| Sharp Grossmont Hospital | La Mesa | California | 91942 | — |
| Yale New Haven Hospital | New Haven | Connecticut | 06510 | — |
| VA Connecticut Healthcare System (VACHS) | West Haven | Connecticut | 06516 | — |
| Cardiology Physicians PA/Red Clay Research, LLC | Newark | Delaware | 19713 | — |
| Bethesda Health | Boynton Beach | Florida | 33435 | — |
| University of Florida Health Jacksonville | Jacksonville | Florida | 32209 | — |
| University of Miami Hospital | Miami | Florida | 33136 | — |
| Cardiology Consultants | Pensacola | Florida | 32501 | — |
| South Miami Heart Specialists | South Miami | Florida | 33143 | — |
| Tampa General Hospital | Tampa | Florida | 33606 | — |
| University of South Florida | Tampa | Florida | 33609 | — |
| Augusta University | Augusta | Georgia | 30912 | — |
| Rush University Medical Center | Chicago | Illinois | 60612 | — |
| Northwestern University | Evanston | Illinois | 60208 | — |
| MMP ME Health Cardiology | Scarborough | Maine | 04074 | — |
| MedStar Shah Medical Group | Charlotte Hall | Maryland | 20622 | — |
| Boston Medical Center | Boston | Massachusetts | 02118 | — |
| Department of Cardiology, K-14 (Henry Ford Health System) | Detroit | Michigan | 48202 | — |
| Regions Hospital and Regions Heart Center Clinic | Saint Paul | Minnesota | 55101 | — |
| University at Buffalo | Buffalo | New York | 14203 | — |
| Advanced Cardiology Group | Buffalo | New York | 14215 | — |
| Montefiore Medical Center | The Bronx | New York | 10467 | — |
| WakeMed | Raleigh | North Carolina | 27610 | — |
| Veterans Affairs North Texas Healthcare System | Dallas | Texas | 75216 | — |
| Houston Methodist Hospital | Houston | Texas | 77030 | — |
| Texas Institute of Cardiology, PA | McKinney | Texas | 75071 | — |
| Victoria Heart and Vascular Center | Victoria | Texas | 77901 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 65 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02656329, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 22, 2019 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02656329 live on ClinicalTrials.gov.